News

Signifor Controls Ectopic Cushing’s Symptoms in Woman for 5 Years

Signifor (pasireotide) treatment was able to control symptoms of ectopic Cushing’s syndrome in a woman for years, according to a case report. The report, “Complete and sustained remission of hypercortisolism with pasireotide treatment of an adrenocorticotropic hormone (ACTH)-secreting thoracic neuroendocrine tumour: an n-of-1 trial,” was published in…

Approved Therapy Recorlev Now Wins FDA Orphan-drug Exclusivity

The U.S. Food and Drug Administration (FDA) has granted Xeris Pharmaceuticals orphan-drug exclusivity for Recorlev (levoketoconazole), its approved treatment for adults with endogenous Cushing’s syndrome. Orphan-drug exclusivity provides the company — which recently acquired the therapy’s developer, Strongbridge Biopharma — seven years of marketing exclusivity for Recorlev…

Case Report: Adrenal Gland Cancer Caused Cushing’s

The case of a woman with adrenal gland cancer that caused Cushing’s syndrome in its advanced stages was described in a recent report. Authors noted this study highlights the difficulties in care for people with aggressive adrenal tumors, which often don’t cause noticeable symptoms until the disease is at a…

Rare Chest Tumor Is Cause of Ectopic Cushing’s in Man, 33: Report

A 33-year-old man with ectopic Cushing’s syndrome saw his symptoms ease after undergoing surgery to remove a rare, slow-growing cancer tumor from his chest. The carcinoid tumor, a type of neuroendocrine tumor, was the cause of the man’s condition, according to researchers. “The patient had complete resolution of symptoms…

Severe Infection and Electrolyte Imbalances May Signal Cushing’s

A severe muscle infection and electrolyte imbalances were among clinical signs leading to a Cushing’s syndrome diagnosis in an 82-year-old woman, according to a recent case report. The patient also showed other cardiovascular risk factors for Cushing’s that aided clinicians in their diagnosis. Infectious complications after a surgery caused the…

Report Ties Antiviral Med to Exogenous Cushing’s

A 49-year-old woman developed exogenous, or therapy-related, Cushing’s syndrome, after being treated with the antiviral Epclusa, which is approved to treat hepatitis C virus infections, a case study reported. “To our knowledge, this is the first time that [Epclusa] has been linked to [exogenous Cushing’s],” the researchers wrote. The study,…